Why BGPT?
logo

Built for bioinformatics workflows

Download raw tables, code snippets, and datasets from full texts to power analyses.







Press Enter ↡ to solve



    Fuel Your Discoveries




     Quick Explanation



    Best evidence (open, reproducible spectral libraries & living platforms)
    The strongest β€œopen + reproducible + library scale” evidence in your prompt centers on community/widely-used MS/MS resources and Dorrestein-associated open libraries/workflows: MSnLib (open multi-stage MSn library with public code + raw data), GNPS/MassIVE + GNPS living curation, and repository-scale reverse metabolomics that operationalizes library use via reproducible public search/propagation.



     Long Explanation



    Evidence battle-test: β€œSpectral libraries, reproducibility, open resources”
    I treat β€œbest evidence” as: open raw data + open code/workflows, documented processing, scalable library/search infrastructure, and some independent/orthogonal validation signalsβ€”while explicitly flagging where claims are library-match hypotheses.
    What’s β€œknown” vs β€œinferred” from the best open evidence
    • Known: MSn Lib provides an open, large-scale MSn spectral library with public metadata/batch files and raw MS data deposited to Zenodo, alongside published workflows/code.
    • Known: GNPS/MassIVE is an open-access infrastructure for data sharing, continuous reanalysis, and community curation via molecular networking, designed as β€œliving data.”
    • Known (protocol-level reproducibility): A Nature Protocols workflow explicitly targets reproducible network generation, sharing, and interpretation on GNPS/MassIVE.
    • Inferred (hypothesis scale): Many high-throughput library hits are best treated as structural hypotheses until orthogonal confirmation (e.g., authentic standards, retention-time concordance, synthesis, NMR). This is explicit in multiple open-library papers: they frequently validate only a subset by standards/orthogonal evidence.
    Visual evidence: scale of open library outputs (from provided paper data)
    Notes on sourcing for plotted values:
    • MSnLib: 2.3M MSn spectra, 357,065 MS2 spectra, 30,008 unique compound structures as reported in the MSnLib summary data excerpt.
    • GNPS libraries: 221,083 MS/MS spectra in GNPS libraries and 18,163 compounds, from the GNPS perspective scale metrics.
    • Conjugated metabolome: 3,412,720 candidate conjugates with single-match support in the β€œNavigating the conjugated metabolome” data excerpt.
    • Reverse metabolomics library: 492,376 spectra linked to 172,483 candidate structures from β€œCharting the Undiscovered Metabolome with Synthetic Multiplexing.”
    Reproducibility chain (end-to-end) β€” where openness helps, where it doesn’t
    • Openness strengthens reproducibility when raw data, processing batches, and code are all publicly reachable (MSnLib + GNPS ecosystems provide this explicitly).
    • Openness does not guarantee correctness at the level of molecular identity: library matching is typically probabilistic and can be confounded by ion formation, adducts, fragments, and metadata mismatches.
    • Validation is often subset-based: e.g., reverse metabolomics and conjugated-metabolome mining report very large predicted/search outputs but confirm only a smaller set via synthesis/standards/orthogonal evidence.
    Critical appraisal (bias, blind spots, and what would change my mind)
    Cited limitations underpinning fragility (no new assumptions):
    • Computational/metadata dependence (MSnLib explicitly lists dependence on computational matching and metadata quality, plus uneven ionization-mode coverage).
    • Putative nature without orthogonal confirmation (GNPS reproducibility protocol highlights that annotations are putative unless validated with standards/orthogonal methods).
    • Bias from public-data heterogeneity (reverse metabolomics and conjugated-metabolome studies mine public repositories and explicitly describe the need for caution about false positives and representation biases; they also report subset validation).
    What would disprove the β€œbest evidence” narrative?
    • If independent groups (with their own processing choices) could not reproduce library matching/propagation patterns at the claimed scale, despite using the open raw data/code, then β€œreproducibility” would be weakened. (This follows directly from the general reproducibility goal embedded in MSnLib’s openness and GNPS protocol’s reproducibility focus.)
    • If large-scale reverse-search outputs did not improve validated identifications (standards/orthogonal) in independent datasets, that would weaken the practical value of spectral-library scale.
    Conflict-of-interest (COI) transparency β€” required for skeptical evaluation
    Why this matters:
    Open resources can still be biased (e.g., selection of what gets validated; framing of limitations). COI doesn’t invalidate methods, but it changes how aggressively to demand independent replication.
    • MSnLib: the excerpt states multiple co-foundership/advisory/equity ties for authors related to mzMine/mzio and other companies.
    • GNPS perspective: the excerpt notes competing financial interests disclosed in the online version.
    • Reverse metabolomics & conjugated metabolome: both include COI statements involving advisory/equity relationships.


    Feedback:   

    Updated: April 22, 2026

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    β€œAll putative GNPS/fragment-based annotations are accurate because repositories are open.” Rejected: GNPS protocol explicitly warns annotations are putative without standards/orthogonal validation and depends on MS2 quality/instrument/library coverage.


    β€œLibrary size guarantees better identifications.” Rejected: multiple cited works explicitly list coverage/ionization-mode imbalance and subset-based validation, meaning scale without representative chemistry or validation can inflate false confidence.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT